1. Concern over potential risks of vanadium use in athletes

   Correspondence 18 January 2013 Pages: 2 - 2

2. Is long-term monitoring necessary with clozapine?

   Comment 18 January 2013 Pages: 2 - 2

3. NSAIDs are contraindicated in patients who are hypersensitive to aspirin

   News item 18 January 2013 Pages: 2 - 2

4. Adverse drug reaction monitoring - the role of the UK pharmacist

   Comment 18 January 2013 Pages: 3 - 3

5. Family of Jakob-Creutzfeldt victim to sue

   Comment 18 January 2013 Pages: 3 - 3

6. Interactions with ACE inhibitors

   Review 18 January 2013 Pages: 3 - 3

7. Lower ketorolac doses recommended

   News item 18 January 2013 Pages: 3 - 3

8. Product news: The final chapter closes on Manoplax (Rm)

   News item 18 January 2013 Pages: 3 - 3

9. Benzodiazepine withdrawal guidelines

   News item 18 January 2013 Pages: 4 - 4

10. Drug interactions with oral contraceptives

    Review 18 January 2013 Pages: 4 - 4

11. Growth hormone may cause gynaecomastia

    Correspondence 18 January 2013 Pages: 4 - 4

12. Risk of renal damage with lithium small

    Review 18 January 2013 Pages: 4 - 4

13. Selective antiarrhythmic resistance to cibenzoline

    Clinical study 18 January 2013 Pages: 4 - 4

14. Acetazolamide

    Case report 18 January 2013 Pages: 5 - 5

15. Acetazolamide

    Incidence study 18 January 2013 Pages: 5 - 5

16. Alcohol

    Incidence study 18 January 2013 Pages: 5 - 5

17. Alteplase

    Case report 18 January 2013 Pages: 5 - 5

18. Amiodarone

    Case report 18 January 2013 Pages: 5 - 5

19. Anaesthetics

    Case report 18 January 2013 Pages: 5 - 5

20. Anaesthetics

    Case report 18 January 2013 Pages: 5 - 5

21. Anaesthetics

    Case reports 18 January 2013 Pages: 5 - 5

22. Antineoplastics

    Incidence study 18 January 2013 Pages: 5 - 5

23. Betaxolol

    Case report 18 January 2013 Pages: 5 - 5

24. Carbamazepine withdrawal

    Clinical study 18 January 2013 Pages: 6 - 6

25. Cisplatin

    Case report 18 January 2013 Pages: 6 - 6

26. Cisplatin

    Incidence study 18 January 2013 Pages: 6 - 6

27. Clozapine

    Incidence study 18 January 2013 Pages: 6 - 6

28. Clozapine

    Comment 18 January 2013 Pages: 6 - 6

29. Contrast media

    Incidence study 18 January 2013 Pages: 6 - 6

30. Cyclosporin

    Case report 18 January 2013 Pages: 6 - 6

31. Cyclosporin

    Case report 18 January 2013 Pages: 6 - 6

32. Cyclosporin

    Case reports 18 January 2013 Pages: 6 - 6

33. Dactinomycin

    Case report 18 January 2013 Pages: 6 - 6

34. Dapsone overdose

    Case report 18 January 2013 Pages: 7 - 7

35. Desipramine overdose

    Case report 18 January 2013 Pages: 7 - 7

36. Digoxin

    Incidence study 18 January 2013 Pages: 7 - 7

37. Disopyramide overdose

    Case report 18 January 2013 Pages: 7 - 7

38. Fludarabine

    Incidence study 18 January 2013 Pages: 7 - 7

39. Fluorouracil

    Case report 18 January 2013 Pages: 7 - 7

40. Gangliosides

    Correspondence 18 January 2013 Pages: 7 - 7

41. Heparin

    Case report 18 January 2013 Pages: 7 - 7

42. Herbal medicine

    Case reports 18 January 2013 Pages: 7 - 7

43. Insulin

    Case report 18 January 2013 Pages: 8 - 8

44. Interferon alpha

    Case reports 18 January 2013 Pages: 8 - 8

45. Interleukin 2

    Clinical study 18 January 2013 Pages: 8 - 8

46. Interleukin 2/interferon alpha 2A

    Case reports 18 January 2013 Pages: 8 - 8

47. Interleukin 2/lymphokine activated killer cells

    Clinical study 18 January 2013 Pages: 8 - 8

48. Levodopa/carbidopa

    Case reports 18 January 2013 Pages: 9 - 9

49. Methotrexate

    Incidence study 18 January 2013 Pages: 9 - 9

50. Methotrexate overdose

    Case report 18 January 2013 Pages: 10 - 10